Breaking News Instant updates and real-time market news.

DHI

D.R. Horton

$74.44 /

+2.62 (+3.65%)

06:17
09/17/20
09/17
06:17
09/17/20
06:17

D.R. Horton price target raised to $81 from $73 at Barclays

Barclays analyst Matthew Bouley raised the firm's price target on D.R. Horton to $81 from $73 and keeps an Overweight rating on the shares. The analyst lifted price targets for the homebuilders by 7% on average following the Barclays' August/September survey. The survey indicates the housing backdrop has remained robust into mid-September, Bouley tells investors in a research note. Bouley remains "tactically positive" on builder stocks, saying the current housing environment is likely to support order strength and pricing into fiscal 2021.

DHI D.R. Horton
$74.44 /

+2.62 (+3.65%)

09/03/20 Credit Suisse
D.R. Horton price target raised to $84 from $77 at Credit Suisse
08/24/20 Zelman
D.R. Horton downgraded to Hold from Buy at Zelman
08/21/20
Fly Intel: Top five analyst downgrades
08/21/20
D.R. Horton downgraded to Neutral from Outperform at Wedbush

TODAY'S FREE FLY STORIES

Periodicals
Oasis Petroleum misses debt payments due Sept. 15, Bloomberg Law reports » 07:50
09/18/20
09/18
07:50
09/18/20
07:50
OAS

Oasis Petroleum

$0.54 /

-0.0228 (-4.07%)

Oasis Petroleum skipped…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OAS Oasis Petroleum
$0.54 /

-0.0228 (-4.07%)

08/06/20 MKM Partners
Oasis Petroleum downgraded to Neutral from Buy at MKM Partners
08/06/20 MKM Partners
Oasis Petroleum downgraded to Neutral from Buy at MKM Partners
06/09/20 Citi
Oasis Petroleum downgraded to Sell from Neutral at Citi
06/09/20 Citi
Oasis Petroleum downgraded to Sell from Neutral at Citi
OAS Oasis Petroleum
$0.54 /

-0.0228 (-4.07%)

OAS Oasis Petroleum
$0.54 /

-0.0228 (-4.07%)

OAS Oasis Petroleum
$0.54 /

-0.0228 (-4.07%)

OAS Oasis Petroleum
$0.54 /

-0.0228 (-4.07%)

Hot Stocks
CHMP recommends approval of Lilly's baricitinib to treat atopic dermatitis » 07:46
09/18/20
09/18
07:46
09/18/20
07:46
LLY

Eli Lilly

$152.49 /

+1.52 (+1.01%)

, INCY

Incyte

$90.32 /

+0.39 (+0.43%)

Eli Lilly and Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$152.49 /

+1.52 (+1.01%)

INCY Incyte
$90.32 /

+0.39 (+0.43%)

LLY Eli Lilly
$152.49 /

+1.52 (+1.01%)

09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
09/03/20
Fly Intel: Top five analyst upgrades
INCY Incyte
$90.32 /

+0.39 (+0.43%)

04:57 Today Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/14/20 Mizuho
Oncology 'fertile ground for M&A activity,' says Mizuho
08/05/20 Mizuho
Incyte price target raised to $95 from $79 at Mizuho
08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
LLY Eli Lilly
$152.49 /

+1.52 (+1.01%)

INCY Incyte
$90.32 /

+0.39 (+0.43%)

LLY Eli Lilly
$152.49 /

+1.52 (+1.01%)

LLY Eli Lilly
$152.49 /

+1.52 (+1.01%)

INCY Incyte
$90.32 /

+0.39 (+0.43%)

LLY Eli Lilly
$152.49 /

+1.52 (+1.01%)

INCY Incyte
$90.32 /

+0.39 (+0.43%)

Recommendations
NeoPhotonics price target lowered to $7 from $11 at DA Davidson » 07:46
09/18/20
09/18
07:46
09/18/20
07:46
NPTN

NeoPhotonics

$6.19 /

-0.09 (-1.43%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NPTN NeoPhotonics
$6.19 /

-0.09 (-1.43%)

NPTN NeoPhotonics
$6.19 /

-0.09 (-1.43%)

09/01/20 MKM Partners
NeoPhotonics price target lowered to $9 from $12 at MKM Partners
09/01/20 B. Riley FBR
B. Riley FBR upgrades NeoPhotonics to Buy on 'de-risked' Huawei exposure
09/01/20 B. Riley FBR
NeoPhotonics upgraded to Buy from Neutral at B. Riley FBR
08/31/20
Fly Intel: Top five analyst downgrades
NPTN NeoPhotonics
$6.19 /

-0.09 (-1.43%)

NPTN NeoPhotonics
$6.19 /

-0.09 (-1.43%)

NPTN NeoPhotonics
$6.19 /

-0.09 (-1.43%)

Recommendations
Combined Nvidia-ARM a long-term risk for AMD, Intel and Vicor, says Northland » 07:45
09/18/20
09/18
07:45
09/18/20
07:45
NVDA

Nvidia

$498.54 /

-2.01 (-0.40%)

, SFTBY

SoftBank

$0.00 /

+ (+0.00%)

, AMD

AMD

$76.55 /

-0.1 (-0.13%)

, INTC

Intel

$50.33 /

-0.04 (-0.08%)

, VICR

Vicor

$81.07 /

-1.34 (-1.63%)

Northland analyst Gus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVDA Nvidia
$498.54 /

-2.01 (-0.40%)

SFTBY SoftBank
$0.00 /

+ (+0.00%)

AMD AMD
$76.55 /

-0.1 (-0.13%)

INTC Intel
$50.33 /

-0.04 (-0.08%)

VICR Vicor
$81.07 /

-1.34 (-1.63%)

NVDA Nvidia
$498.54 /

-2.01 (-0.40%)

09/15/20 Needham
Nvidia price target raised to $700 from $600 at Needham
09/15/20 Craig-Hallum
Nvidia price target raised to $500 from $480 at Craig-Hallum
09/15/20 Oppenheimer
Nvidia's acquisition of ARM strengthens AI hand, says Oppenheimer
09/15/20 Citi
Citi lays out five reasons to favor of Nvidia's ARM acquisition
SFTBY SoftBank
$0.00 /

+ (+0.00%)

09/15/20 Craig-Hallum
Nvidia price target raised to $500 from $480 at Craig-Hallum
09/15/20 Oppenheimer
Nvidia's acquisition of ARM strengthens AI hand, says Oppenheimer
09/14/20 Deutsche Bank
ARM customers could push back on Nvidia deal, says Deutsche Bank
09/14/20 RBC Capital
RBC Capital sees ARM Holdings deal as positive for Nvidia, negative for Intel
AMD AMD
$76.55 /

-0.1 (-0.13%)

09/09/20 Lynx
Lynx raises outlook for AMD to a $110B market cap, price expectation in the $90s
09/02/20 Wells Fargo
New processors should make Intel more competitive with AMD, says Wells Fargo
09/02/20 Goldman Sachs
Nvidia price target raised to $585 from $528 at Goldman Sachs
09/01/20 Goldman Sachs
AMD price target raised to $84 from $50 at Goldman Sachs
INTC Intel
$50.33 /

-0.04 (-0.08%)

09/15/20 Craig-Hallum
Nvidia price target raised to $500 from $480 at Craig-Hallum
09/14/20 RBC Capital
RBC Capital sees ARM Holdings deal as positive for Nvidia, negative for Intel
09/08/20 Standpoint Research
Intel upgraded to Buy from Hold at Standpoint Research
09/08/20 Goldman Sachs
Goldman sticks with Sell on Apple despite 71% rally since downgrade
VICR Vicor
$81.07 /

-1.34 (-1.63%)

07/24/20 BWS Financial
Vicor price target raised to $100 from $84 at BWS Financial
06/17/20 Craig-Hallum
Vicor price target raised to $85 from $65 at Craig-Hallum
06/15/20 Needham
Vicor price target raised to $80 from $60 at Needham
05/27/20 BWS Financial
Vicor initiated with a Buy at BWS Financial
NVDA Nvidia
$498.54 /

-2.01 (-0.40%)

AMD AMD
$76.55 /

-0.1 (-0.13%)

INTC Intel
$50.33 /

-0.04 (-0.08%)

VICR Vicor
$81.07 /

-1.34 (-1.63%)

  • 11
    Jun
NVDA Nvidia
$498.54 /

-2.01 (-0.40%)

SFTBY SoftBank
$0.00 /

+ (+0.00%)

AMD AMD
$76.55 /

-0.1 (-0.13%)

INTC Intel
$50.33 /

-0.04 (-0.08%)

NVDA Nvidia
$498.54 /

-2.01 (-0.40%)

SFTBY SoftBank
$0.00 /

+ (+0.00%)

AMD AMD
$76.55 /

-0.1 (-0.13%)

INTC Intel
$50.33 /

-0.04 (-0.08%)

NVDA Nvidia
$498.54 /

-2.01 (-0.40%)

AMD AMD
$76.55 /

-0.1 (-0.13%)

INTC Intel
$50.33 /

-0.04 (-0.08%)

Recommendations
F5 Networks price target lowered to $140 from $160 at MKM Partners » 07:42
09/18/20
09/18
07:42
09/18/20
07:42
FFIV

F5 Networks

$123.24 /

-0.27 (-0.22%)

MKM Partners analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FFIV F5 Networks
$123.24 /

-0.27 (-0.22%)

FFIV F5 Networks
$123.24 /

-0.27 (-0.22%)

07/28/20 Needham
F5 Networks price target raised to $180 from $170 at Needham
07/28/20 Credit Suisse
F5 Networks price target raised to $183 from $170 at Credit Suisse
07/27/20 RBC Capital
F5 Networks price target raised to $154 from $135 at RBC Capital
07/24/20 Wolfe Research
F5 Networks initiated with an Outperform at Wolfe Research
FFIV F5 Networks
$123.24 /

-0.27 (-0.22%)

FFIV F5 Networks
$123.24 /

-0.27 (-0.22%)

FFIV F5 Networks
$123.24 /

-0.27 (-0.22%)

FFIV F5 Networks
$123.24 /

-0.27 (-0.22%)

Recommendations
Nike price target raised to $121 from $115 at Raymond James » 07:42
09/18/20
09/18
07:42
09/18/20
07:42
NKE

Nike

$116.36 /

-2.24 (-1.89%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$116.36 /

-2.24 (-1.89%)

NKE Nike
$116.36 /

-2.24 (-1.89%)

06:34 Today Barclays
Nike price target raised to $132 from $118 at Barclays
09/16/20 Piper Sandler
Nike price target raised to $130 from $112 at Piper Sandler
09/15/20 BTIG
Nike price target raised to $140 from $117 at BTIG
09/15/20 Deutsche Bank
Nike price target raised to $107 from $87 at Deutsche Bank
NKE Nike
$116.36 /

-2.24 (-1.89%)

NKE Nike
$116.36 /

-2.24 (-1.89%)

NKE Nike
$116.36 /

-2.24 (-1.89%)

NKE Nike
$116.36 /

-2.24 (-1.89%)

Recommendations
Lumentum price target lowered to $90 from $98 at Raymond James » 07:40
09/18/20
09/18
07:40
09/18/20
07:40
LITE

Lumentum

$70.80 /

-0.57 (-0.80%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LITE Lumentum
$70.80 /

-0.57 (-0.80%)

LITE Lumentum
$70.80 /

-0.57 (-0.80%)

06:50 Today Morgan Stanley
Morgan Stanley upgrades II-VI to Overweight on diversification
09/16/20 Barclays
Lumentum price target lowered to $90 from $105 at Barclays
09/14/20 Susquehanna
Lumentum weakness a buying opportunity, says Susquehanna
09/10/20 Northland
Next gen ROADMs potential not priced into Lumentum shares, says Northland
LITE Lumentum
$70.80 /

-0.57 (-0.80%)

LITE Lumentum
$70.80 /

-0.57 (-0.80%)

LITE Lumentum
$70.80 /

-0.57 (-0.80%)

LITE Lumentum
$70.80 /

-0.57 (-0.80%)

General news
Treasury Market Outlook: bonds are firmer and equities are narrowly mixed » 07:40
09/18/20
09/18
07:40
09/18/20
07:40

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Centric Brands announces bankruptcy court confirmation for reorganization plan » 07:37
09/18/20
09/18
07:37
09/18/20
07:37
CTRC

Centric Brands

$0.00 /

+ (+0.00%)

, BX

Blackstone

$52.16 /

-1.36 (-2.54%)

Centric Brands (CTRC)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTRC Centric Brands
$0.00 /

+ (+0.00%)

BX Blackstone
$52.16 /

-1.36 (-2.54%)

CTRC Centric Brands
$0.00 /

+ (+0.00%)

BX Blackstone
$52.16 /

-1.36 (-2.54%)

06/25/20
Fly Intel: Top five analyst initiations
06/25/20 UBS
Blackstone initiated with a Buy at UBS
06/08/20 Citi
Citi downgrades Alternative Asset Managers to Market Weight, lowers four ratings
06/08/20 Citi
Blackstone downgraded to Neutral from Buy at Citi
BX Blackstone
$52.16 /

-1.36 (-2.54%)

BX Blackstone
$52.16 /

-1.36 (-2.54%)

CTRC Centric Brands
$0.00 /

+ (+0.00%)

BX Blackstone
$52.16 /

-1.36 (-2.54%)

CTRC Centric Brands
$0.00 /

+ (+0.00%)

BX Blackstone
$52.16 /

-1.36 (-2.54%)

Upgrade
Dave & Buster's upgraded at Raymond James, stock pullback seems 'overdone' » 07:35
09/18/20
09/18
07:35
09/18/20
07:35
PLAY

Dave & Buster's

$14.13 /

-4.99 (-26.10%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

06:33 Today Stifel
Stifel upgrades Dave & Buster's to Buy, calls pullback a chance to 'level up'
04:47 Today Stifel
Dave & Buster's upgraded to Buy from Hold at Stifel
04:46 Today Raymond James
Dave & Buster's upgraded to Outperform from Market Perform at Raymond James
09/17/20 Truist
Truist says Dave & Buster's dip on 'unfounded' bankruptcy worries an opportunity
PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

  • 04
    May
PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

PLAY Dave & Buster's
$14.13 /

-4.99 (-26.10%)

Recommendations
AES Corp. price target raised to $23.50 from $19 at Morgan Stanley » 07:35
09/18/20
09/18
07:35
09/18/20
07:35
AES

AES Corp.

$18.44 /

+0.385 (+2.13%)

, GOOGL

Alphabet Class A

$1,487.80 /

-26.37 (-1.74%)

, GOOG

Alphabet

$1,495.81 /

-26.12 (-1.72%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AES AES Corp.
$18.44 /

+0.385 (+2.13%)

GOOGL Alphabet Class A
$1,487.80 /

-26.37 (-1.74%)

GOOG Alphabet
$1,495.81 /

-26.12 (-1.72%)

AES AES Corp.
$18.44 /

+0.385 (+2.13%)

08/13/20 BofA
AES Corp. added to US 1 List; Ameren removed at BofA
05/20/20 Seaport Global
Seaport Global starts power and competitive retail sector with positive outlook
05/20/20 Seaport Global
AES Corp. initiated with a Buy at Seaport Global
04/02/20 RBC Capital
AES Corp. upgraded to Outperform from Sector Perform at RBC Capital
GOOGL Alphabet Class A
$1,487.80 /

-26.37 (-1.74%)

09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Alphabet initiated with an Overweight at KeyBanc
09/14/20 KeyBanc
Alphabet initiated with an Overweight at KeyBanc
08/12/20 JPMorgan
Broadcom likely co-designed Google's next-gen AI chip, says JPMorgan
GOOG Alphabet
$1,495.81 /

-26.12 (-1.72%)

09/14/20 KeyBanc
Alphabet initiated with an Overweight at KeyBanc
08/25/20 UBS
Alphabet price target raised to $1,970 from $1,600 at UBS
08/12/20 JPMorgan
Broadcom likely co-designed Google's next-gen AI chip, says JPMorgan
08/03/20 Goldman Sachs
ADT Inc. price target raised to $17 from $9 at Goldman Sachs
AES AES Corp.
$18.44 /

+0.385 (+2.13%)

GOOGL Alphabet Class A
$1,487.80 /

-26.37 (-1.74%)

GOOG Alphabet
$1,495.81 /

-26.12 (-1.72%)

GOOGL Alphabet Class A
$1,487.80 /

-26.37 (-1.74%)

GOOG Alphabet
$1,495.81 /

-26.12 (-1.72%)

GOOGL Alphabet Class A
$1,487.80 /

-26.37 (-1.74%)

GOOG Alphabet
$1,495.81 /

-26.12 (-1.72%)

GOOGL Alphabet Class A
$1,487.80 /

-26.37 (-1.74%)

GOOGL Alphabet Class A
$1,487.80 /

-26.37 (-1.74%)

Options
Unusual call flow in option market yesterday » 07:35
09/18/20
09/18
07:35
09/18/20
07:35
AAPL

Apple

$110.35 /

-1.72 (-1.53%)

, TSLA

Tesla

$423.17 /

-18.87 (-4.27%)

, MAT

Mattel

$11.87 /

+0.42 (+3.67%)

, HOG

Harley-Davidson

$25.77 /

-0.69 (-2.61%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$110.35 /

-1.72 (-1.53%)

TSLA Tesla
$423.17 /

-18.87 (-4.27%)

MAT Mattel
$11.87 /

+0.42 (+3.67%)

HOG Harley-Davidson
$25.77 /

-0.69 (-2.61%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

06:16 Today Citi
Citi boosts Jabil target to $45 from $40, adds 'Catalyst Watch'
09/17/20 BWS Financial
AXT rumors of Apple win highlight value, says BWS Financial
09/17/20 Jefferies
Apple price target raised to $135 from $116.25 at Jefferies
09/16/20 B. Riley FBR
AXT Inc. shares may be overreacting to Apple Watch 6 news, says B. Riley FBR
TSLA Tesla
$423.17 /

-18.87 (-4.27%)

09/17/20 Piper Sandler
Tesla price target raised to $515 from $480 at Piper Sandler
09/17/20 Baird
Tesla could unveil lower cost battery at Battery Day event, says Baird
09/16/20 Credit Suisse
Tesla price target raised to $400 from $280 at Credit Suisse
09/16/20 Deutsche Bank
Tesla price target raised to $400 from $300 at Deutsche Bank
MAT Mattel
$11.87 /

+0.42 (+3.67%)

07/24/20 MKM Partners
Mattel price target raised to $13 from $9 at MKM Partners
06/03/20
Fly Intel: Top five analyst upgrades
06/03/20 Jefferies
Jefferies upgrades Mattel to Buy with $13 price target
06/03/20 Jefferies
Mattel upgraded to Buy from Hold at Jefferies
HOG Harley-Davidson
$25.77 /

-0.69 (-2.61%)

09/17/20 Longbow
Harley-Davidson losing share among first-time bike buyers, says Longbow
07/16/20
Fly Intel: Top five analyst upgrades
07/16/20 Wedbush
Wedbush upgrades Harley-Davidson to Buy on increase in demand
07/16/20 Wedbush
Harley-Davidson upgraded to Outperform from Neutral at Wedbush
AAPL Apple
$110.35 /

-1.72 (-1.53%)

TSLA Tesla
$423.17 /

-18.87 (-4.27%)

MAT Mattel
$11.87 /

+0.42 (+3.67%)

HOG Harley-Davidson
$25.77 /

-0.69 (-2.61%)

  • 14
    Feb
AAPL Apple
$110.35 /

-1.72 (-1.53%)

TSLA Tesla
$423.17 /

-18.87 (-4.27%)

HOG Harley-Davidson
$25.77 /

-0.69 (-2.61%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

TSLA Tesla
$423.17 /

-18.87 (-4.27%)

MAT Mattel
$11.87 /

+0.42 (+3.67%)

HOG Harley-Davidson
$25.77 /

-0.69 (-2.61%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

TSLA Tesla
$423.17 /

-18.87 (-4.27%)

MAT Mattel
$11.87 /

+0.42 (+3.67%)

HOG Harley-Davidson
$25.77 /

-0.69 (-2.61%)

AAPL Apple
$110.35 /

-1.72 (-1.53%)

Syndicate
Humanigen 8M share IPO priced at $8.50 » 07:34
09/18/20
09/18
07:34
09/18/20
07:34
HGEN

Humanigen

$0.00 /

+ (+0.00%)

JPMorgan and Jefferies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 18
    Sep
Hot Stocks
Auxly Cannabis files early warning report » 07:34
09/18/20
09/18
07:34
09/18/20
07:34
CBWTF

Auxly Cannabis

$0.00 /

+ (+0.00%)

Auxly Cannabis announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

07/16/20 Desjardins
Auxly Cannabis initiated with a Buy at Desjardins
CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

CBWTF Auxly Cannabis
$0.00 /

+ (+0.00%)

Hot Stocks
Progenity announces addition to Russell 2000 Index » 07:33
09/18/20
09/18
07:33
09/18/20
07:33
PROG

Progenity

$9.17 /

-0.15 (-1.61%)

Progenity announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PROG Progenity
$9.17 /

-0.15 (-1.61%)

PROG Progenity
$9.17 /

-0.15 (-1.61%)

08/17/20 Piper Sandler
ACOG recommendation 'extremely' positive for Natera and Progenity, says Piper
08/17/20 Baird
ACOG bulletin positive for prenatal testing players, says Baird
07/23/20 Piper Sandler
Piper encouraged Progenity settlement finalized, says company fully reserved
07/15/20
Fly Intel: Top five analyst initiations
PROG Progenity
$9.17 /

-0.15 (-1.61%)

  • 19
    Jun
PROG Progenity
$9.17 /

-0.15 (-1.61%)

Hot Stocks
Veru presents results from Phase 1b study of VERU-111 » 07:32
09/18/20
09/18
07:32
09/18/20
07:32
VERU

Veru

$2.89 /

+0.12 (+4.34%)

Veru announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VERU Veru
$2.89 /

+0.12 (+4.34%)

VERU Veru
$2.89 /

+0.12 (+4.34%)

01/22/20 Cantor Fitzgerald
Veru still in 'early innings' despite 117% rally, says Cantor Fitzgerald
01/21/20 H.C. Wainwright
Veru price target raised to $6 from $4.50 at H.C. Wainwright
VERU Veru
$2.89 /

+0.12 (+4.34%)

Initiation
Strategic Education initiated with a Hold at Truist » 07:31
09/18/20
09/18
07:31
09/18/20
07:31
STRA

Strategic Education

$93.80 /

+1.09 (+1.18%)

Truist analyst Tobey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STRA Strategic Education
$93.80 /

+1.09 (+1.18%)

STRA Strategic Education
$93.80 /

+1.09 (+1.18%)

07/30/20 Barrington
Strategic Education earnings selloff a buying opportunity, says Barrington
07/30/20 Sidoti
Strategic Education upgraded to Buy from Neutral at Sidoti
05/20/20 Sidoti
Strategic Education initiated with a Neutral at Sidoti
02/28/20 Barrington
Strategic Education continues consistent performance, says Barrington
STRA Strategic Education
$93.80 /

+1.09 (+1.18%)

  • 06
    Aug
Downgrade
Seres Therapeutics downgraded to Neutral from Buy at Chardan » 07:28
09/18/20
09/18
07:28
09/18/20
07:28
MCRB

Seres Therapeutics

$26.85 /

-0.5 (-1.83%)

, EVLO

Evelo Biosciences

$4.95 /

-0.05 (-1.00%)

, FBRX

Forte Biosciences

$48.28 /

+4.26 (+9.68%)

, KLDO

Kaleido Biosciences

$5.88 /

-0.25 (-4.08%)

, SYBX

Synlogic

$2.18 /

-0.07 (-3.11%)

Chardan analyst Gbola…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCRB Seres Therapeutics
$26.85 /

-0.5 (-1.83%)

EVLO Evelo Biosciences
$4.95 /

-0.05 (-1.00%)

FBRX Forte Biosciences
$48.28 /

+4.26 (+9.68%)

KLDO Kaleido Biosciences
$5.88 /

-0.25 (-4.08%)

SYBX Synlogic
$2.18 /

-0.07 (-3.11%)

MCRB Seres Therapeutics
$26.85 /

-0.5 (-1.83%)

08/18/20
Fly Intel: Top five analyst initiations
08/18/20 Piper Sandler
Seres Therapeutics initiated with an Overweight at Piper Sandler
08/11/20 H.C. Wainwright
Seres Therapeutics price target raised to $41 from $8 at H.C. Wainwright
08/11/20 Jefferies
Seres Therapeutics upgraded to Buy from Hold at Jefferies
EVLO Evelo Biosciences
$4.95 /

-0.05 (-1.00%)

07/02/20 BMO Capital
Evelo Biosciences price target lowered to $17 from $21 at BMO Capital
05/21/20 Morgan Stanley
Morgan Stanley downgrades Evelo to Equal Weight after AD discontinuation
05/21/20 Morgan Stanley
Evelo Biosciences downgraded to Equal Weight from Overweight at Morgan Stanley
05/12/20 Jefferies
Evelo Biosciences downgraded to Hold from Buy at Jefferies
FBRX Forte Biosciences
$48.28 /

+4.26 (+9.68%)

09/10/20 Chardan
Forte Biosciences price target raised to $60 from $45 at Chardan
08/28/20 Chardan
Forte Biosciences upgraded to Buy from Neutral at Chardan
08/28/20 Brookline
Forte Biosciences initiated with a Buy at Brookline
08/25/20 Truist
Forte Biosciences initiated with a Buy at Truist
KLDO Kaleido Biosciences
$5.88 /

-0.25 (-4.08%)

05/21/20 Morgan Stanley
Morgan Stanley downgrades Kaleido to Equal Weight amid delays for key programs
05/21/20 Morgan Stanley
Kaleido downgraded to Equal Weight from Overweight at Morgan Stanley
SYBX Synlogic
$2.18 /

-0.07 (-3.11%)

05/21/20 Piper Sandler
Piper Sandler remains Overweight on Synlogic after AbbVie ends collaboration
03/30/20 Piper Sandler
Synlogic's SYNB1819 Phase 1 enrollment slowed by COVID-19, says Piper Sandler
01/09/20 Piper Sandler
Piper Sandler reiterated Buy on Synlogic after 2020 program outlook
11/13/19 Piper Jaffray
Synlogic price target lowered to $7 from $10 at Piper Jaffray
MCRB Seres Therapeutics
$26.85 /

-0.5 (-1.83%)

EVLO Evelo Biosciences
$4.95 /

-0.05 (-1.00%)

KLDO Kaleido Biosciences
$5.88 /

-0.25 (-4.08%)

SYBX Synlogic
$2.18 /

-0.07 (-3.11%)

  • 13
    Aug
  • 25
    Jun
  • 02
    Jun
MCRB Seres Therapeutics
$26.85 /

-0.5 (-1.83%)

EVLO Evelo Biosciences
$4.95 /

-0.05 (-1.00%)

FBRX Forte Biosciences
$48.28 /

+4.26 (+9.68%)

KLDO Kaleido Biosciences
$5.88 /

-0.25 (-4.08%)

MCRB Seres Therapeutics
$26.85 /

-0.5 (-1.83%)

FBRX Forte Biosciences
$48.28 /

+4.26 (+9.68%)

Upgrade
Foot Locker upgraded to Buy from Hold at Argus » 07:28
09/18/20
09/18
07:28
09/18/20
07:28
FL

Foot Locker

$35.95 /

-0.62 (-1.70%)

Argus analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FL Foot Locker
$35.95 /

-0.62 (-1.70%)

FL Foot Locker
$35.95 /

-0.62 (-1.70%)

09/08/20
Fly Intel: Top five analyst initiations
09/08/20 Goldman Sachs
Foot Locker initiated with a Buy at Goldman Sachs
08/24/20 Deutsche Bank
Foot Locker price target lowered to $33 from $35 at Deutsche Bank
08/11/20 Barclays
Dick's Sporting price target raised to $51 from $45 at Barclays
FL Foot Locker
$35.95 /

-0.62 (-1.70%)

FL Foot Locker
$35.95 /

-0.62 (-1.70%)

FL Foot Locker
$35.95 /

-0.62 (-1.70%)

FL Foot Locker
$35.95 /

-0.62 (-1.70%)

Initiation
Limelight Networks initiated with a Buy at Truist » 07:27
09/18/20
09/18
07:27
09/18/20
07:27
LLNW

Limelight Networks

$5.86 /

+0.16 (+2.81%)

Truist analyst Greg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LLNW Limelight Networks
$5.86 /

+0.16 (+2.81%)

LLNW Limelight Networks
$5.86 /

+0.16 (+2.81%)

07:24 Today Truist
Limelight Networks initiated with a Buy at Truist
07/21/20 Lake Street
Limelight Networks price target raised to $9 from $8 at Lake Street
07/17/20 B. Riley FBR
Limelight Networks price target raised to $9 from $7.50 at B. Riley FBR
07/17/20 William Blair
William Blair starts Cloudflare at Outperform, says warrants premium
LLNW Limelight Networks
$5.86 /

+0.16 (+2.81%)

LLNW Limelight Networks
$5.86 /

+0.16 (+2.81%)

LLNW Limelight Networks
$5.86 /

+0.16 (+2.81%)

Initiation
Limelight Networks initiated with a Buy at Truist » 07:24
09/18/20
09/18
07:24
09/18/20
07:24
LLNW

Limelight Networks

$5.86 /

+0.16 (+2.81%)

Truist analyst Greg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LLNW Limelight Networks
$5.86 /

+0.16 (+2.81%)

LLNW Limelight Networks
$5.86 /

+0.16 (+2.81%)

07/21/20 Lake Street
Limelight Networks price target raised to $9 from $8 at Lake Street
07/17/20 B. Riley FBR
Limelight Networks price target raised to $9 from $7.50 at B. Riley FBR
07/17/20 William Blair
William Blair starts Cloudflare at Outperform, says warrants premium
06/26/20 Raymond James
Limelight Networks price target raised to $8.50 from $6 at Raymond James
LLNW Limelight Networks
$5.86 /

+0.16 (+2.81%)

LLNW Limelight Networks
$5.86 /

+0.16 (+2.81%)

LLNW Limelight Networks
$5.86 /

+0.16 (+2.81%)

Syndicate
Vitru 6M share IPO priced at $16.00 » 07:21
09/18/20
09/18
07:21
09/18/20
07:21
VTRU

Vitru

$0.00 /

+ (+0.00%)

The deal priced at low…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 18
    Sep
Initiation
Aravive initiated with an Outperform at William Blair » 07:21
09/18/20
09/18
07:21
09/18/20
07:21
ARAV

Aravive

$5.81 /

-0.26 (-4.28%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARAV Aravive
$5.81 /

-0.26 (-4.28%)

ARAV Aravive
$5.81 /

-0.26 (-4.28%)

07/23/20 H.C. Wainwright
Aravive price target raised to $26 from $15 at H.C. Wainwright
04/30/20 Piper Sandler
Aravive partnering with WuXi to develop CCN2 antibodies, says Piper Sandler
03/27/20 H.C. Wainwright
Aravive price target lowered to $15 from $25 at H.C. Wainwright
02/18/20 Piper Sandler
IDMC recommends dose escalation in Aravive trial, says Piper Sandler
ARAV Aravive
$5.81 /

-0.26 (-4.28%)

  • 27
    Nov
Hot Stocks
Bristol-Myers receives CHMP opinion recommending approval of Opdivo/Yervoy combo » 07:21
09/18/20
09/18
07:21
09/18/20
07:21
BMY

Bristol-Myers

$59.40 /

-0.06 (-0.10%)

Bristol Myers said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$59.40 /

-0.06 (-0.10%)

BMY Bristol-Myers
$59.40 /

-0.06 (-0.10%)

08/25/20 Piper Sandler
Bristol's trial miss has 'no financial impact' on Agios, says Piper Sandler
08/06/20 Citi
Investors can refocus on Bristol-Myers story after Eliquis win, says Citi
07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
07/28/20
Fly Intel: Top five analyst initiations
BMY Bristol-Myers
$59.40 /

-0.06 (-0.10%)

BMY Bristol-Myers
$59.40 /

-0.06 (-0.10%)

BMY Bristol-Myers
$59.40 /

-0.06 (-0.10%)

BMY Bristol-Myers
$59.40 /

-0.06 (-0.10%)

Recommendations
Facebook price target raised to $295 from $285 at Morgan Stanley » 07:18
09/18/20
09/18
07:18
09/18/20
07:18
FB

Facebook

$254.91 /

-8.69 (-3.30%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$254.91 /

-8.69 (-3.30%)

FB Facebook
$254.91 /

-8.69 (-3.30%)

09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Facebook initiated with an Overweight at KeyBanc
09/14/20 KeyBanc
Facebook initiated with an Overweight at KeyBanc
09/02/20 JPMorgan
Peloton price target raised to $105 from $58 at JPMorgan
FB Facebook
$254.91 /

-8.69 (-3.30%)

FB Facebook
$254.91 /

-8.69 (-3.30%)

FB Facebook
$254.91 /

-8.69 (-3.30%)

FB Facebook
$254.91 /

-8.69 (-3.30%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.